MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 215 filers reported holding MIRATI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,046,158 | +18.3% | 92,887 | -1.9% | 1.26% | +34.5% |
| Q2 2023 | $3,421,511 | +25.0% | 94,700 | +28.7% | 0.94% | +14.1% |
| Q1 2023 | $2,736,448 | -17.9% | 73,600 | 0.0% | 0.82% | -12.7% |
| Q4 2022 | $3,334,816 | -33.3% | 73,600 | +2.8% | 0.94% | -30.2% |
| Q3 2022 | $5,001,000 | -6.4% | 71,600 | -10.1% | 1.34% | -7.7% |
| Q2 2022 | $5,344,000 | +52.2% | 79,600 | +86.4% | 1.46% | +59.2% |
| Q1 2022 | $3,511,000 | +40.4% | 42,700 | +95.0% | 0.92% | +26.9% |
| Q2 2020 | $2,500,000 | -22.7% | 21,893 | -48.0% | 0.72% | -46.6% |
| Q1 2020 | $3,236,000 | – | 42,102 | – | 1.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |